Rare diseases
Investigational molecules
Locations
Ulitsa Hristo Stanchev 15, 1463 Sofia, Bulgaria
Dkc Fokus-5 Lzip OOD in Sofia, Bulgaria specialises in clinical trials of conditions such as Hidradenitis, Psoriatic arthropathy, Dermatitis atopic, Systemic lupus erythematosus, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in Systemic Lupus Erythematosus, focusing on innovative therapies to manage this complex autoimmune disease. The center's research aims to improve patient outcomes by exploring new treatment modalities and assessing their safety and efficacy.
Through these studies, the center contributes significantly to understanding and managing SLE, offering hope for improved therapeutic strategies.
Specializing in Hidradenitis Suppurativa, the center is dedicated to advancing treatment options for this chronic skin condition. By evaluating novel therapeutic agents, the center aims to enhance the quality of life for patients suffering from this debilitating disease.
The research conducted here is pivotal in developing effective treatments that address both the physical and psychological impacts of the condition.
The center is a leader in researching Dermatomyositis and Polymyositis, focusing on reducing muscle symptoms and improving patient outcomes. The research explores the efficacy of new treatments in managing these inflammatory myopathies.
These studies are crucial in developing therapies that can significantly improve the quality of life for patients with these conditions.
Focusing on Rheumatoid Arthritis, the center is committed to advancing treatment options for this chronic inflammatory disorder. The research aims to evaluate the efficacy and safety of various therapeutic agents in managing the disease.
Through these studies, the center contributes to the development of more effective and safer treatment options for patients with rheumatoid arthritis.
The center is pioneering research in Alopecia Areata, focusing on understanding and treating this autoimmune condition that causes hair loss. The research evaluates the long-term safety and efficacy of novel treatments.
This research is vital in developing therapies that can restore hair growth and improve the quality of life for patients affected by alopecia areata.
Specializing in Psoriatic Arthritis, the center is dedicated to improving treatment strategies for this inflammatory arthritis associated with psoriasis. The research focuses on evaluating the efficacy of new therapeutic agents.
The center's research efforts are crucial in developing effective treatments that address both joint and skin symptoms of psoriatic arthritis.
The center is at the forefront of research in Gout with Hyperuricemia, focusing on developing effective treatments to manage uric acid levels and prevent gout flares. The research evaluates the efficacy of new medications compared to standard treatments.
This research is essential in providing new therapeutic options that can better manage gout and improve patient outcomes.
Clinical trials currently enrolling participants at this site.
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
BulgariaLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
BulgariaA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
BulgariaA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
BulgariaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
BulgariaLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
BulgariaStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
BulgariaPhase 2b Randomized Double‑Blind Study of Oral PF‑08049820 in Adults with Moderate to Severe Atopic Dermatitis
BulgariaA study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa
BulgariaA study to evaluate the effectiveness of NAV-240 in adults with moderate-to-severe hidradenitis suppurativa
BulgariaEvaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study
BulgariaStudy on the Long-Term Safety of Dazukibart in Patients with Idiopathic Inflammatory Myopathies, Including Dermatomyositis and Polymyositis
BulgariaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
